The top after-market NASDAQ gainers Monday were: Landec Corp, Endocyte, ISTA Pharmaceuticals, MDC Partners Inc, Ku6 Media Co, Kratos Defense & Security Solutions, Energy Recovery, Primo Water Corp, Computer Task Group and OraSure Technologies.

Landec Corp. (LNDC) stock climbed 12.14 percent to $7.85 in post market session. Its third quarter net profit surged to $4.8 million or $0.18 per share from $2.3 million or $0.09 per share in the same period a year-ago, while analysts’’ expected net profit of $0.13 per share.

Endocyte, Inc. (ECYT) stock climbed 8.86 percent to $5.90 in post market session. The company announced that three poster presentations will be presented by Endocyte scientists at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) to be held in Chicago, Ill., March 31 through April 4.

ISTA Pharmaceuticals, Inc. (ISTA) stock climbed 8 percent to $9.05 in aftermarket session. Bausch & Lomb announced Monday that they have signed a definitive agreement under which the company will acquire ISTA for $9.10 per share in cash or a total of approximately $500 million.

MDC Partners Inc. (MDCA) stock surged 5.24 percent to $12.46 in aftermarket session. The company stock plunged more than 5 percent in regular session.

Ku6 Media Co., Ltd. (KUTV) stock gained 5 percent to $2.10 in aftermarket trading.

Kratos Defense & Security Solutions, Inc. (KTOS) advanced 3.56 percent to $6.11 in post market session. The stock has a 52-week low of $4.61, a 52-week high of $14.39 and $191.63 million in market capitalization.

Energy Recovery, Inc. (ERII) stock advanced 3.15 percent to $2.29 in post market session.

Primo Water Corp. (PRMW) stock gained 3.02 percent to $2.05 in aftermarket session. The company stock declined more than 2 percent in regular session.

Computer Task Group, Inc. (CTGX) stock gained 2.25 percent to $15.45 in aftermarket session.

OraSure Technologies, Inc. (OSUR) stock rose 2.17 percent to $11.29 in post market session after surging more than 3 percent in regular trading.

Cancer Cancer